Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT03298360
Eligibility Criteria:
Inclusion Criteria:
* Patients who participated to ANRS139 TRIO trial, and still followed in centers
* Who remained in virological success since the participation at the trial: 90% of HIV-1 RNA level less than 50 copies/mL : one or more blips less than 1000 copies/mL are tolerated
* Genotypic resistance profiles available at baseline and before trial
* Age ≥ 18 years
* Affiliate or beneficiary of a social security system (the State Medical Aid or AME is not a social security system).
* Written informed consent signed by the person and the investigator before any exam performed in the study.
Exclusion Criteria:
* HIV-1 RNA level ≥ 1000 copies/mL at least once since the end of the 139 TRIO trial
* Patient participating in another research evaluating other treatments with an exclusion period ongoing at the screening visit.
* Person under legal guardianship or deprived of liberty by a judicial or administrative decision.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03298360
Study Brief:
Protocol Section:
NCT03298360